LDL vs. HDL – Why One is Bad and the Other Good

Overview of Blood Cholesterol Transport

  • Cholesterol circulates in the blood packaged inside lipoproteins—micelles composed of lipid cores and protein shells.
  • Two clinically important classes:
    • Low-Density Lipoproteins (LDL) – colloquially “bad” cholesterol.
    • High-Density Lipoproteins (HDL) – colloquially “good” cholesterol.
  • Key factors that determine whether a class is beneficial or harmful:
    • Lipid-to-protein ratio.
    • Direction of transport (liver → peripheral tissue vs. peripheral tissue → liver).
    • Interactions with vascular endothelium.
    • Propensity to deposit or remove cholesterol from artery walls.

Composition & Cargo

  • LDL
    • High lipid, low protein content after leaving liver.
    • Core packed with cholesteryl esters + triacylglycerols.
    • Apolipoprotein B-100 (ApoB-100) is the main structural protein.
  • HDL
    • High protein, low lipid content when released from liver/intestine.
    • Contains apolipoprotein A-I (ApoA-I) as its signature protein.
    • Acts as a “reverse cholesterol shuttle.”

Origin & Processing in the Liver

  • Assembly
    • Both classes originate in the liver where lipids are packaged with apolipoproteins using the ER & Golgi.
  • Metabolic fate
    • LDL is secreted as VLDL → IDL → LDL as triglycerides are hydrolyzed.
    • HDL is secreted as nascent, discoidal particles → mature, spherical HDL after loading peripheral cholesterol.
  • Re-entry
    • HDL delivers collected cholesterol via scavenger receptor class B type I (SR-B1) back to hepatocytes for bile acid synthesis/excretion.

Behaviour in the Bloodstream

  • LDL (Bad Tendencies)
    • Tendency to deliver cholesterol to peripheral tissues—including adipose and arterial walls.
    • If plasma concentration rises, LDL can become oxidized.
    • Oxidized LDL is taken up by macrophages → foam cells → atherosclerotic plaques.
    • Plaque formation narrows the arterial lumen, impeding blood flow, heightening risk of MI\text{MI} and stroke.
  • HDL (Good Tendencies)
    • Removes/“scavenges” excess cholesterol from peripheral tissues & artery walls.
    • Contains lecithin–cholesterol acyltransferase (LCAT) → esterifies free cholesterol, trapping it in the core.
    • Delivers cholesterol to liver for disposal or to steroidogenic tissues.
    • Antioxidant enzymes (paraoxonase) within HDL protect LDL from oxidation.

Net Cardiovascular Impact

  • Elevated LDL → higher risk of atherosclerosis.
  • Elevated HDL → protective; correlates inversely with cardiovascular events.
  • Ratio Total CholesterolHDL\dfrac{\text{Total Cholesterol}}{\text{HDL}} often used clinically; lower ratios desirable (< 44).

Practical / Clinical Connections

  • Lifestyle: Diet rich in saturated fats ↑ LDL; aerobic exercise ↑ HDL.
  • Pharmacology: Statins ↓ hepatic cholesterol synthesis → upregulate LDL receptors → ↓ circulating LDL.
  • Genetic disorders (e.g., familial hypercholesterolemia) involve defective LDL receptor → skyrocketing LDL.

Ethical & Public Health Implications

  • Access to lipid-lowering drugs impacts health equity.
  • Nutrition policy (food labeling, trans-fat bans) designed to reduce population LDL.